Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.86 USD | +0.46% | +11.96% | +52.38% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.38% | 2.45B | |
+72.98% | 12.38B | |
-20.40% | 7.76B | |
+6.24% | 6.61B | |
+12.78% | 5.4B | |
+38.73% | 4.96B | |
-17.25% | 4.75B | |
-24.72% | 3.89B | |
-29.57% | 2.66B | |
+2.48% | 1.98B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 03